miR-296-5p、Skp2、RPL6与前列腺癌病理特征的关系及对手术预后的影响  

Association of miR-296-5p,S-phase kinase-associated protein 2,and ribosomal protein L6 with the pathological features of prostate cancer and their influence on surgical prognosis

作　　者：张灿峰 刘嘉欣 杨文博 Zhang Canfeng;Liu Jiaxin;Yang Wenbo(Urology 2nd Ward,The Fourth Clinical College of Xinxiang Medical College;Critical Care Medicine 1st Ward,Xinxiang Central Hospital,The Fourth Clinical College of Xinxiang Medical College)

机构地区：[1]新乡市中心医院/新乡医学院第四临床学院泌尿外科二病区,新乡453000 [2]新乡市中心医院/新乡医学院第四临床学院重症医学科一区,新乡453000

出　　处：《重庆医科大学学报》2025年第2期198-203,共6页Journal of Chongqing Medical University

基　　金：2023年度河南省医学科技攻关计划资助项目(编号:LHGJ20230885)。

摘　　要：目的:探讨微小RNA-296-5p、S期激酶相关蛋白2(S-phase kinase-associated protein 2,Skp2)、核糖体蛋白L6(ribosomal protein L6,RPL6)与前列腺癌病理特征的关系及对手术预后的影响。方法:选取2018年1月至2023年1月120例前列腺患者,均行腹腔镜前列腺癌术治疗,对比不同病理特征患者miR-296-5p、Skp2、RPL6 mRNA表达水平,分析各指标与病理特征的关系。根据术后1年是否生化复发分为复发组(n=21)与未复发组(n=97),比较2组临床资料、miR-296-5p、Skp2、RPL6mRNA表达水平,分析miR-296-5p、Skp2、RPL6对手术预后的影响及预测价值。结果:不同病理分期、Gleason评分、术前血清前列腺特异性抗原(prostate specific antigen,PSA)水平、淋巴结转移患者miR-296-5p、Skp2、RPL6 mRNA表达水平比较,差异有统计学意义(F=12.927、22.416、10.088、34.239、20.180、12.208,t=4.649、-5.770、-5.713、4.716、-5.647、-6.884,均P=0.000);miR-296-5p与Gleason评分、病理分期、术前血清前列腺特异性抗原(prostate specific antigen,PSA)水平、淋巴结转移呈负相关(r=-0.578、-0.539、-0.517、-0.556,均P<0.001),Skp2、RPL6 mRNA与Gleason评分、病理分期、术前血清PSA水平、淋巴结转移呈正相关(r=0.531、0.507、0.476、0.493、0.494、0.473、0.420、0.505,均P<0.001);复发组淋巴结转移、病理分期、切缘阳性率、Gleason评分、高于未复发组,术后辅助治疗率低于未复发组(P<0.05);复发组miR-296-5p表达水平低于未复发组,Skp2、RPL6mRNA表达水平高于未复发组(P<0.05);校正前,logistic回归分析,病理分期、Gleason评分、淋巴结转移、切缘阳性、术后辅助治疗、miR-296-5p、Skp2、RPL6 mRNA是前列腺癌患者术后生化复发的影响因素(P<0.05),校正后,miR-296-5p、Skp2、RPL6mRNA仍是前列腺癌患者术后生化复发的影响因素(P<0.05);miR-296-5p、Skp2、RPL6联合预测前列腺术后生化复发的AUC为0.902(95%CI=0.833~0.949),大于各指标单独预测(P<0.05)。结论:前�Objective:To explore the relationship between microRNA-296-5p(miR-296-5p),S-phase kinase-associated protein 2(Skp2),ribosomal protein L6(RPL6)and pathological characteristics of prostate cancer,as well as their impact on surgical prognosis.Methods:A total of 120 patients with prostate cancer who were treated from January 2018 to January 2023 were enrolled,and all patients underwent laparoscopic therapy for prostate cancer.The mRNA expression levels of miR-296-5p,Skp2,and RPL6 were compared between the patients with different pathological features,and the association between each indicator and pathological features was analyzed.According to the presence or absence of recurrence at 1 year after surgery,the patients were divided into recurrence group with 21 patients and non-recurrence group with 97 patients.The two groups were compared in terms of clinical data and the mRNA expression levels of miR-296-5p,Skp2,and RPL6,and the influence of miR-296-5p,Skp2,and RPL6 on surgical prognosis and their predictive value were analyzed.Results:There were statistically significant differences in the expression levels of miR-296-5p,Skp2,and RPL6 mRNA among patients with different pathological stages,Gleason scores,preoperative serum prostate specific antigen(PSA)levels,and lymph node metastasis(F=12.927,22.416,10.088,34.239,20.180,12.208;t=4.649,-5.770,-5.713,4.716,-5.647,-6.884;P=0.000 for all).miR-296-5p was negatively correlated with Gleason score,pathological stage,preoperative serum PSA level,and lymph node metastasis(r=-0.578,-0.539,-0.517,-0.556;P<0.001 for all),while Skp2 and RPL6 mRNA were positively correlated with Gleason score,pathological stage,preoperative serum PSA level,and lymph node metastasis(r=0.531,0.507,0.476,0.493,0.494,0.473,0.420,0.505;P<0.001 for all).Compared with the non-recurrence group,the recurrence group had significantly higher lymph node metastasis,pathological stage,rate of positive margin,and Gleason score and a significantly lower rate of postoperative adjuvant therapy(P<0.05).Compared with

关 键 词：微小RNA-296-5p S期激酶相关蛋白2 核糖体蛋白L6 前列腺癌 病理特征 手术 预后 

分 类 号：R114[医药卫生—卫生毒理学]